| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
recombinant fusion protein IL-6 - IL-2
1
relevant articles (0 outcomes,
0 trials/studies)
found for this Bio-Agent
Description: a human recombinant fusion protein; more potent than IL-2 and/or IL6; MW 37 kDa; has been sequenced
Also Known As:CH925
Bio-Agent Context: Research Results
Related Diseases
| 1. | Viremia
12/01/1995
- "At the completion of the experiment there was a inhibition of viremia with the CH925 and IL-2 + IL-6. "
Order ALL the reference details at left... |
| 2. | Infection
12/01/1995
- "It is suggested that CH925 might be a potential remedy in HBV infection treatment."
12/01/1995 - "The effects of CH925, a novel immune modulator, on hepadna virus infection was evaluated. " 12/01/1995 - "The role of recombinant human fusion protein IL-6/IL-2 (CH925) in hepadna virus infection treatment." Order ALL the reference details at left... |
Related Drugs and Biologics
| 1. | Interleukin-6 (Interleukin 6)
|
| 2. | Interleukin-2 (IL2)
|
Best Treatments:
Research Summary Report
on Viremia
Research Summary Report
on Viremia
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
CureHunter research summary reports will vary in length from 25 to 250 pages.
Analytic charts allow you and your physicians to see at a glance your
medication options—including new, promising, off-label and experimental
all rated for clinical efficacy.
- Free Updates for 1 Year
- All 197 Outcomes
- Top 200 Key Drugs and Biologics
- Top 50 Key Therapies and Procedures
- Detailed History Charts
- Full Research Reference Details
- Sample PDF Report on Psoriasis >>
| Price: | $24.00
& Delivery via
PDF download
updates for 1 year |
Research Interface
- Unlimited Disease, Drug and Therapy Search
- 2 clicks from Disease to Drug to Evidence
- Trial References
- All the Positive Outcomes
- Detailed Relationship Timeline Charts
- Full Article Reference Details
- Includes Mobile Interface Subscription
- One-click to FDA Products/Patents
- Request Institution License Details >>
| Price: | $490.00
access via web interface 1 year subscription |
Mobile Interface
- Access from any web enabled PDA or Phone
- Trial references
- All the Positive Outcomes
- Drug and Therapy searches
- Full Article Reference Details
- Try Mobile Interface >>
| Price: | $45.00
access via "curehunter.com/m" 1 year subscription |